Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp

Vaccine

Volumn 30, Issue 42, 2012, Pages 6034-6039

  Farag, Mohamed M S ^a,b   Tedjokusumo, Raindy ^c   Flechtenmacher, Christa ^a   Asen, Theresa ^c   Stremmel, Wolfgang ^a   Müller, Martina ^d   Protzer, Ulrike ^c   Weigand, Kilian ^d  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Al Azhar University   (Egypt)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Antigen presenting cells; Dendritic cells; HBc protein; HBs protein; HBV sub viral particles; Hepatitis B virus

Indexed keywords

LIPOPOLYSACCHARIDE; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINATION; VIRUS PARTICLE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; HEP G2 CELLS; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SPLEEN; VIRION;

EID: 84865560260     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.057     Document Type: Article

References (30)

1. Ganem D., Prince A.M. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004, 350:1118-1129.
2. Williams R. Global challenges in liver disease. Hepatology 2006, 44:521-526.
3. Maynard J.E., Kane M.A., Hadler S.C. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis 1989, 11(Suppl 3):S574-S578.
4. Jung M.C., Pape G.R. Immunology of hepatitis B infection. Lancet Infect Dis 2002, 2:43-50.
5. Rehermann B. Immune responses in hepatitis B virus infection. Semin Liver Dis 2003, 23:21-38.
6. Kakimi K., Isogawa M., Chung J., Sette A., Chisari F.V. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J Virol 2002, 76:8609-8620.
7. Zheng B.J., Zhou J., Qu D., Siu K.L., Lam T.W., Lo H.Y., et al. Selective functional deficit in dendritic cell - T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J Viral Hepat 2004, 11:217-224.
8. Beckebaum S., Cicinnati V.R., Zhang X., Ferencik S., Frilling A., Grosse-Wilde H., et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 2003, 109:487-495.
9. Akbar S.M., Furukawa S., Horiike N., Onji M. Vaccine therapy for hepatitis B virus carrier. Curr Drug Targets Infect Disord 2004, 4:93-101.
10. Shimizu Y., Guidotti L.G., Fowler P., Chisari F.V. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998, 161:4520-4529.
11. Jiang W.Z., Fan Y., Liu X., Zhang Y.L., Wen J.J., Hao W.L., et al. Therapeutic potential of dendritic cell-based immunization against HBV in transgenic mice. Antiviral Res 2008, 77:50-55.
12. Chen W., Shi M., Shi F., Mao Y., Tang Z., Zhang B., et al. HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes. Hepatol Res 2009, 39:355-365.
13. Lohr H.F., Pingel S., Bocher W.O., Bernhard H., Herzog-Hauff S., Rose-John S., et al. Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B - restoration by exogenous interleukin-12. Clin Exp Immunol 2002, 130:107-114.
14. Farag M.M., Hoyler B., Encke J., Stremmel W., Weigand K. Dendritic cells can effectively be pulsed by HBVsvp and induce specific immune reactions in mice. Vaccine 2010, 29:200-206.
15. Guidotti L.G., Matzke B., Schaller H., Chisari F.V. High-level hepatitis B virus replication in transgenic mice. J Virol 1995, 69:6158-6169.
16. Protzer U., Seyfried S., Quasdorff M., Sass G., Svorcova M., Webb D., et al. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 2007, 133:1156-1165.
17. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176:1693-1702.
18. Untergasser A., Zedler U., Langenkamp A., Hosel M., Quasdorff M., Esser K., et al. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 2006, 43:539-547.
19. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002, 20:621-667.
20. van der Molen R.G., Sprengers D., Binda R.S., de Jong E.C., Niesters H.G., Kusters J.G., et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004, 40:738-746.
21. Oka Y., Akbar S.M., Horiike N., Joko K., Onji M. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice. Immunology 2001, 103:90-97.
22. Huang Y., Chen Z., Jia H., Wu W., Zhong S., Zhou C. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg. Clin Immunol 2006, 119:280-290.
23. Chaiken I.M., Williams W.V. Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design. Trends Biotechnol 1996, 14:369-375.
24. Guidotti L.G., Matzke B., Pasquinelli C., Shoenberger J.M., Rogler C.E., Chisari F.V. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice. J Virol 1996, 70:7056-7061.
25. Zhou C., Peng G., Jin X., Tang J., Chen Z. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine. Clin Immunol 2010, 137:190-198.
26. Chen X., Lai J., Pan Q., Tang Z., Yu Y., Zang G. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice. Vaccine 2010, 28:3913-3919.
27. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284:825-829.
28. Liao W., Ou J.H. Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs. J Virol 1995, 69:1025-1029.
29. Weigand K., Knaust A., Schaller H. Assembly and export determine the intracellular distribution of hepatitis B virus core protein subunits. J Gen Virol 2010, 91:59-67.
30. Protzer U., Maini M.K., Knolle P.A. Living in the liver: hepatic infections. Nat Rev Immunol 2012, 12:201-213.